Becker’s Hospital Review list ranks GMC among tops in nation
CONTACT: Matthew Van Stone: 570-808-3248, email@example.com
July 31, 2014
FOR IMMEDIATE RELEASE:
DANVILLE, Pa. – Geisinger Medical Center (GMC) has been named one of the “100 Hospitals and Health Systems with Great Oncology Programs” by Becker’s Hospital Review. According to Becker’s, this year’s honorees are “leading the way in terms of quality patient care, cancer outcomes and research.”
The Becker's Hospital Review editorial team selected hospitals for inclusion based on rankings and awards they have received from a variety of reputable sources. The following awards were considered as part of the criteria for inclusion on the list: U.S. News & World Report cancer rankings, Truven Health Analytics, CareChex cancer care rankings, National Cancer Institute designations, the American College of Surgeons Commission on Cancer accreditations, American Nurses Credentialing Center designations and awards and Blue Distinction Center recognition from the BlueCross BlueShield Association.
“Earning a spot on Becker’s ‘100 Hospitals with Great Oncology Programs’ is as affirming a recognition of quality cancer care as any other our facility could have received,” said James Wade (at right), M.D., chairman, Geisinger Cancer Institute. “It’s our unique approach to cancer care that treats each patient as an individual case with customized treatments that we feel sets us apart and distinguishes our center as a premier destination for cancer care.”
Joining GMC on the list of “100 Hospitals with Great Oncology Programs” were esteemed medical centers such as the Cleveland Clinic, Ohio; Mayo Clinic, Rochester, Minn.; Memorial Sloan-Kettering Cancer Center, New York City; John Hopkins Kimmel Cancer Center, Baltimore; and Yale-New Haven Hospital, Conn. GMC was one of just seven Pennsylvania hospitals to make the list and the only one not located in Philadelphia or Pittsburgh.
Earlier this month, GMC was listed among Becker’s list of “100 Great Hospitals” when it was also ranked 74th nationally in the National Patient Engagement Rankings. Geisinger also recently partnered with German tumor repository and bio bank Indivumend to utilize Geisinger samples to further cancer research and develop new individualized treatments for certain types of cancer.